In this study, we tested the hypothesis that dietary linoleic acid intake controls the arterial blood plasma linoleic acid concentration and the rates of tumor growth and linoleic acid metabolism in vivo. Seven groups of young male Buffalo rats (11-21 rats/group) were given free access to semipurified diets containing different amounts of corn and/or olive oils. Four other groups (7-11 rats/group) were 30% energy-restricted. Each experiment included periods for rat growth and plasma lipid stabilization (6 wk), measurement of mean daily arterial blood plasma fatty acid concentrations (3 wk), surgical implantation of a subcutaneous tissue-isolated hepatoma 7288CTC, tumor growth and harvest (2-4 wk). Linoleic / arachidonic acid (P Å 0.007) and oleic acid (P Å 0.002) concentrations in arterial blood plasma were increased as dietary intake of linoleic and oleic acids was increased, respectively. In rats given free access to food, tumor growth was directly dependent on the plasma concentrations of linoleic (P õ 0.001) and arachidonic acids (P Å 0.04). Tumor growth in energy-restricted rats was dependent only on the linoleic acid concentration (P Å 0.008). Energy restriction itself caused a growth inhibition independent of plasma linoleic acid. The linoleic acid and total fatty acid concentrations of tumor triacylglycerols were directly dependent on the plasma linoleic acid concentration in rats given free access to food (P Å 0.009). Hepatoma 7288CTC (both in vivo and during perfusion in situ) supported a dose-dependent conversion (P õ 0.001) of plasma linoleic acid to the mitogen, 13-hydroxy-9,11-octadecadienoic acid. We conclude that increased arterial blood plasma linoleic acid concentrations, caused by increased dietary intakes, specifically stimulate growth, lipid storage and linoleic acid metabolism in hepatoma 7288CTC in vivo. KEY WORDS: • linoleic acid • hepatoma 7288CTC • tumor growth • tumor lipid content • 13-hydroxyoctadecadienoic acid • rats 1 Supported by The Stephen C. Clark Research Fund of Bassett HealthCare. 2 The costs of publication of this article were defrayed in part by the payment rial blood plasma, resulting from increased linoleic acid ingesof page charges. This article must therefore be hereby marked ''advertisement'' tion, have a direct stimulative effect on tumor growth and in accordance with 18 USC section 1734 solely to indicate this fact. 3 To whom correspondence and reprint requests should be addressed. linoleic acid metabolism in vivo (Sauer and Dauchy 1988).
Dietary fat has an important role in the growth of spontanethat the fatty acid itself or a metabolite initiated or enhanced ous, chemically induced and transplantable tumors in rodents specific tumor growth processes. The mechanism of tumor (Klurfeld 1995) . High fat diets, in particular those containing growth stimulation by dietary linoleic acid is not yet known. linoleic acid as a major fatty acid, were shown to increase Previous studies performed in this laboratory showed that the growth rates of established rodent tumors (Abraham and increased plasma concentrations of linoleic and arachidonic Hillyard 1983, Hillyard and Abraham 1979) and human tumor acids were responsible for the increase in tumor growth rate xenografts in nude mice (Rose et al. 1993 , Wang et al. 1995 .
observed in vivo during an acute fast (Sauer et al. 1986 ). Solid Diets supplemented with pure arachidonic acid were ineffectumors in vivo removed linoleic and arachidonic acids from tive (Hillyard and Abraham 1979) . Increased dietary linoleic the arterial blood in concentration-and supply-dependent proacid also appeared to increase the weights of chemically incesses (Sauer and Dauchy 1992a) . Also, incorporation of 3 Hduced mammary tumors in 25% energy-restricted rats (Klurfeld thymidine into DNA of hepatoma 7288CTC perfused in situ et al. 1989 ). The stimulative effects of dietary linoleic acid on was directly dependent on the ambient arterial blood concentumor growth rate (Rao and Abraham 1976) and chemically trations and uptakes of linoleic and arachidonic acids (Sauer induced carcinogenesis (Ip et al. 1985 , Roebuck et al. 1985 and Dauchy 1988 and 1992b) , suggesting that the fatty acids were saturable processes. These studies defined a unique tumor were the active agents that interacted with the tumor. Rates growth requirement for linoleic acid in vivo and suggested of 3 H-thymidine incorporation were about three times faster with linoleic acid than with arachidonic acid; oleic and palmitic acids were not active (Sauer and Dauchy 1992b) . We proposed that increased concentrations of linoleic acid in arte-DIETARY AND PLASMA LINOLEIC ACID AND TUMOR GROWTH 70% of the mean amount of food eaten the day before by cohort rats
The experiments performed in this study were designed to test given free access to food. All rats were fed at 1500 h and uneaten this hypothesis. rations were discarded. Animal weights were recorded weekly. Arterial blood collection. After 6-8 wk of consuming these diets, a series of six arterial blood samples was collected from each rat over
MATERIALS AND METHODS
an 18-d period. The blood collections were separated by 4-h intervals to encompass a 24-h feeding period; consecutive blood collections Animals, tumors and tumor implantation. Male Buffalo (BUF/ NCR) rats (4-5 wk old) weighing 35-100 g were purchased from were spaced 3 d apart to minimize morbidity and effects on feeding activity. The animals were anesthesized by CO 2 inhalation and the Charles River Laboratories, Kingston, NY. The animals had free access to water and were subjected to alternate 12-h periods of dark samples collected by heart puncture in 1 mL syringes moistened with sodium heparin (1 1 10 6 U/L, Elkin-Sinn, Cherry Hill, NJ). The and light (0600 to 1800 h) during the entire experiment. There was no light contamination during the dark phase. Temperature and procedure was designed to collect oxygenated blood from the left ventricle. Mortality resulting from CO 2 anesthesia was increased humidity were maintained at 23ЊC and 40-60%, respectively. Rats were fed nonpurified diet (Prolab rat, mouse, hamster 1000 formula, among the energy-restricted rat groups; otherwise, the rats were active and began feeding immediately after the procedures. Blood samples Agway, Syracuse, NY) for 1 wk before the start of the experimental diets. All experiments were performed with Morris hepatoma were centrifuged for 10 min at 10,000 1 g to remove red cells, and the plasma was frozen at 020ЊC. Tumors were implanted 3 d after 7288CTC grown subcutaneously as tissue-isolated tumors (Sauer et al. 1982) . A brief description of the implantation procedure is as the final blood collection. Lipid extraction and analysis. Plasma free and total plasma, tu-follows: the skin over the lower abdomen and groin of a rat anesthetized with sodium pentobarbital (25 mg/kg, Abbot Laboratories, mor and dietary fatty acids were extracted as previously described Dauchy 1988 and 1992a) . All tumors were carefully North Chicago, IL) was shaved and cleaned with Betadine solution (Purdue Frederick, Norwalk, CT). An incision was made to expose cleaned of external fat on removal from the rat; microscopic examination showed that adipose tissue was not present in the tumor interior the vessels in the left inguinal region. The deep branches of the femoral vessels and the femoral vein distal to the origin of the super- (Sauer et al. 1982) . The portions of sample extracted were as follows: 0.1-0.2 mL plasma, 0.1 mL of a 20% homogenate of tumor tissue ficial epigastric vein were ligated. The superficial epigastric artery and vein were cleaned of adherent fat and ligated about 2 cm distal to and 25 mg diet. Heptadecanoic acid (100 mg) was added as an internal standard before extraction. The major lipid classes in plasma and their origin from the femoral vessels to form a vascular stalk; a 3-mm cube of tumor tissue was sutured to the end of this vascular stalk. The tumor were separated by TLC, eluted from the resin, saponified and the fatty acids methylated. Internal standards for each lipid class were tumor implant and adjacent stalk were enclosed in a small Parafilm envelope (American National Can, Greenwich, CT), placed in the added to the plasma and tumor homogenates before extraction and TLC. Lipid extracts were saponified in methanolic-NaOH (0.5 mmol/ inguinal fossa and the skin incision was closed. Vascular connections to the epigastric vessels form within the Parafilm envelope during L) for 5 min at 100ЊC and the fatty acids methylated using boron triflouride-methanol reagent for 2 min at 100ЊC. Fatty acid methyl tumor-initiated angiogenesis. These tumors typically lack a central necrotic region seen in subcutaneous implants that obtain their blood esters were measured using a Hewlett-Packard (Palo Alto, CA) model 5890A gas chromatograph equipped with a flame-ionization detector, supply from the periphery (Sauer et al. 1982) . The latent period between implantation and first evidence of a subcutaneous tumor was an integrator (model 3396A) and autoinjector (model 7673S). Separations were performed on a 0.25 mm 1 30 m capillary column recorded, and the weight of the established tumor was estimated every other day over a 10-to 18-d period (Sauer et al. 1986) . Growth rates (model 2330, Supelco Inc., Bellefonte, PA) at 190ЊC with helium as the carrier gas (linear gas rate, 19 cm/s). Fatty acid methyl esters were of individual tumors (g/d) represent the slopes of linear regression lines developed from these data. The actual tumor weight (measured identified by their retention times compared with known standards. Plasma and tumor fatty acid concentrations were expressed as mmol/ on the day of harvest) was the final point in the regression. Tumor growth rates for a group are means { SEM of the rates determined L plasma or mmol/g tumor wet weight, respectively. Plasma free fatty acid concentrations were 20-25% of the total concentration. for individual rats.
Arteriovenous difference measurements for plasma lipids and lipid Mean daily arterial blood plasma fatty acid concentrations were calculated for each dietary group. This value is the mean { SEM metabolites across tissue-isolated hepatoma 7288CTC perfused in situ were performed as previously described (Sauer and Dauchy 1988 and of averages determined from the six time points. Unless otherwise indicated, all plasma fatty acid levels reported below are the mean 1992b). [ 14 C(U)]-Linoleic acid (38.7 GBq/mmol) was purchased from NEN Products, Boston, MA and [1-14 C]-arachidonic acid (2.04 GBq/ daily arterial blood plasma levels for the dietary group. Measurement of linoleic and arachidonic acid metabolites. Art-mmol) was purchased from American Radiolabeled Chemicals, St. Louis, MO. Tumors for perfusion weighed 4-6 g and were collected erial and venous blood plasma samples (0.2-0.6 mL) collected in vivo or during tumor perfusions in situ were analyzed by HPLC and from Buffalo rats fed either the 5% corn oil diet or nonpurified diet. Donor blood was collected at 0800-1000 h from adult male Sprague-TLC. For HPLC analysis, an internal standard, 3.1 nmol ({) 5-hydroxyeicosatrienoic acid 4 (5-HETE), was added and the sample Dawley rats (250-300 g) fed nonpurified diet. In some experiments, the lipid concentration of the donor blood was increased by depriving was acidified with 50 mL glacial acetic acid. After extraction on a C 18 -PrepSep column (Fisher Scientific, Pittsburgh, PA) prewashed the donor rats of food for 24 h. All procedures were approved by the Institutional Animal Care and Use Committee.
with 10 mL methanol and 10 mL water, the lipids were eluted with 4 mL methanol and evaporated to dryness under nitrogen. The residue Diet preparation and feeding regimens. Semipurified experimental diets were prepared weekly using ingredients purchased from U.S. was taken up in 30% methanol and the metabolites separated on a C 18 Ultrasphere column (5 mm; 4.6 1 250 mm; Altex Scientific, Beck-Biochemical, Cleveland, OH. The diets were formulated to provide different amounts of linoleic and oleic acids and to contain a fixed man Instruments, Berkeley, CA) using an ISCO (Lincoln, NE) model 2350 pump with 80% methanol/20% water/0.01% acetic acid as the amount of dietary oil (10%), different amounts of corn oil (2, 5, 7.5 or 10%) or no added oil (fat-free). The individual ingredients used mobile phase at a flow rate of 1.0 mL/min. The effluent was monitored at 235 and 279 nm using an ISCO variable wavelength detector and in these preparations are listed in Table 1 . The concentrations of the six major fatty acids in the different diets were increased in the peaks integrated and quantified using the ISCO ChemResearch software program. The extinction coefficients used were: 13-hydroxy-proportion to the type and content of the dietary oil ( Table 2) . All diets contained 0.5 g BHT (Sigma Chemical, St. Louis, MO)/1500 9,11-octadecadienoic acid (13-HODE), 23,000; 13-keto-9,11-octadeg diet and were stored in sealed plastic bags at 020ЊC. Rats with free access to food were housed two rats per cage, whereas the energyrestricted rats were housed singly. The experimental diets were fed cadienoic acid (13-KODE), 22,300; and 5-HETE, 27,000. 13-HODE Chemicals, Ann Arbor, MI, were added before chromatography to enhance detection of the compounds on the chromatogram. Portions in tumor venous blood plasma was identified by mass spectrometry and by comparing retention times during HPLC, R F values during of the tumor homogenate were extracted and chromatographed as described (Sauer and Dauchy 1992a) . Tracer amounts of 3 H-oleic TLC and UV absorption spectra with a 13-HODE standard. Ultraviolet absorption spectra of samples and standards were recorded using acid, [9,10-3 H(N)]-triolein (931.6 GBq/mmol) and [2-palmitoyl-9,10-3 H(N)]-L-a-dipalmitoylphosphatidylcholine (1.2 TBq/mmol), pur-a Hewlett-Packard 8452A diode array spectrophotometer (Palo Alto, CA) with 1 mL methanol as the solvent and blank.
chased from NEN, were added before extraction for recovery estimation. Radiolabeled compounds were measured by liquid scintillation; Plasma and tumor samples collected during tumor perfusions with 14 C-linoleic and 14 C-arachidonic acids were also analyzed by TLC.
counting efficiency was determined by internal standardization. Statistical analysis. Results are expressed as means { SEM. The Plasma samples extracted on C 18 -PrepSep columns, as described above, were chromatographed on polysilicic acid-impregnated glass effects of dietary fat concentration on mean daily arterial blood plasma fatty acid levels and on tumor growth rates within dietary fiber sheets (ITLC SA, Gelman Sciences, Ann Arbor, MI) using diethyl ether/hexane/acetic acid, 25:74:1, as the solvent system. regimens were examined by one-way ANOVA. When differences among the dietary groups were detected, means were compared using Tracer amounts of [9,10-3 H(N)]-oleic acid (273.8 GBq/mmol), purchased from NEN, were added before extraction to estimate recovery.
Student-Newman-Keuls multiple comparison test (Glantz 1992) . Relationships between tumor growth rates and plasma fatty acid levels Standard carriers, 9-hydroxy-10,12-octadecadienoic acid (9-HODE), 13-HODE, 13-KODE, 5-, 12-, and 15-HETE, purchased from Cayman for the dietary groups within and between the dietary regimens were CO diet are shown in the left panel of Figure 1 . Plasma TFA and EFA concentrations measured in energy-restricted rats fed RESULTS the 7.5% CO diet are shown in the middle panel. Plasma TFA is the sum of the eight major plasma fatty acids observed in the Dietary fat and rat and tumor growth. The number of dietary groups: myristic, palmitic, palmitoleic, stearic, oleic, rats/dietary group, duration of the dietary treatments, food linoleic, arachidonic and 5, 8, 11-eicosatrienoic acid. Signifiintake during the period of blood collection, mean rat carcass cant increases (P õ 0.05) in plasma concentrations of both weights, tumor growth rates and final tumor weights for dietary TFA and EFA were observed daily during and for 4 h after groups in the two feeding regimens are listed in Table 3 .
the dark period for rat groups given free access to food. In the Each dietary group contained 12-15 rats at the start of the energy-restricted rats, these increases occurred immediately experiment. Data for rats given free access to the 5% corn oil after the feeding at 1500 h. Plasma TFA and linoleic acid diet were compiled from two groups of 12 rats each. Death concentrations in the arterial blood of the energy-restricted from anaesthesia, cardiac tamponade during blood collection rats were 35-45% lower (P õ 0.05) than those in the plasma and from tumor-bearing caused the decreases in group sizes.
of cohort groups given free access to food. Mortality from these causes was greatest among the energy-Plasma lipids in rats given free access to the fat-free diet restricted rats; the 7.5% corn oil group contained 14 rats and were synthesized from protein and carbohydrate and showed the other three groups initially contained 12 rats.
no feeding-related diurnal variations in plasma fatty acid con-Mean carcass weights for rats given free access to food were centrations (Fig. 1, right panel) . 5, 8, 11-Eicosatrienoic acid, a 330-355 g at time of tumor implantations, except for rats fatty acid formed in animals fed low levels of linoleic acid, (312 g) fed the fat-free diet. Mean tumor growth rates (Table was present in the plasma of these rats. The mean trienoic:te-3) differed significantly (P Å 0.001) among these groups. The traenoic ratio measured over the 3-wk period of blood collecfastest growth rate was observed in rats given free access to tion in rats fed the fat-free diet was 0.31 { 0.001 (mean { the 10% corn oil (CO) diet; the slowest rates were observed SEM, n Å 84 determinations), indicating an essential fatty acid in rats fed the fat-free and 10% olive oil (OV) diets. Tumor deficiency (van Egmond et al. 1996) . Weekly weight gains growth rates in the energy-restricted rat groups were also induring the 8-wk period before tumor implantation for the rat creased (P Å 0.02) by an increase in dietary corn oil. Differgroups given free access to either the fat-free or the 7.5% CO ences among the individual rat groups are listed in Table 3. diets were 33.1 and 35.6 g/wk (Table 3) , respectively, indicat-Dietary fat and arterial blood plasma fatty acid concentraing that the essential fatty acid deficiency in rats fed the fattions. Diurnal variations in arterial blood fatty acid concentrations were observed in rat groups on both feeding regimens.
free diet had only a small effect on rat carcass growth.
/ 4w20$$0019 06-02-97 22:50:31 nutras LP: J Nut July FIGURE 1 Diurnal variations in total and essential fatty acids (linoleic / arachidonic acids) in arterial blood plasma of rats given free access to food or energy-restricted. Time of feeding was 1500 h. Blood samples were collected by heart puncture at the times designated. Each point is a mean { SEM; n Å 13 and 14 rats/group for rats given free access to the 7.5% corn oil or fat-free diets, respectively, and n Å 10 for energyrestricted rats. Means { SEM for the six measurements are mean daily arterial blood plasma concentrations. Concentrations with asterisks are different (P õ 0.05) from concentrations without asterisks.
Plasma linoleic plus arachidonic acid concentrations were concentrations in the diets containing added fat (Table 2) , the concentrations of these saturated fatty acids were not dif-significantly increased in rat groups given free access to food (P Å 0.007) and in energy-restricted (P Å 0.005) rat groups ferent (P ú 0.05) in the six rat groups given free access to diets containing added fat and in the four energy-restricted as the linoleic acid concentration of the diet increased. As judged from the average amount of diet consumed per rat groups. However, plasma linoleic acid concentrations were increased (P Å 0.001) by an increased dietary linoleic acid (Table 3 ) and the dietary linoleic acid concentration (Table  2) , each rat in the groups fed 10% CO, 7.5% CO, 5% CO / concentration (Table 2 ) and were independent of the total dietary fat concentration; plasma linoleic acid concentrations 5% OV, 5% CO, 2% CO, 10% OV and the fat-free diets consumed Ç 3.9, 3.5, 2.4, 2.0, 0.60, 0.64 and 0.04 mmol did not differ in groups given free access to the 2% CO and 10% OV diets and the 5% CO / 5% OV and 7.5% CO diets linoleic acid/d, respectively. Plasma EFA concentrations were 4.95 { 0.06, 4.1 { 0.02, 4.16 { 0.02, 3.45 { 0.11, 2.95 { and in energy-restricted groups fed the 7.5 and 10% CO diets. Plasma linoleic acid concentrations differed (P õ 0.05) among 0.03, 2.9 { 0.03 and 0.84 { 0.02 mmol/L plasma, respectively, in these rat groups (Fig. 2) . Daily linoleate intakes for individ-the other dietary groups in each feeding regimen. Plasma arachidonic acid concentrations, which were a function of the ual energy-restricted rats consuming the 10% CO, 7.5% CO, 5% CO / 5% OV and 2% CO diets were 2.8, 2.5, 1.6 and dietary linoleic acid content and the feeding regimen (Fig. 2) , were not different in the four energy-restricted rat groups. 0.42 mmol/d, respectively. Plasma EFA concentrations in these energy-restricted rat groups were: 2.81 { 0.02, 2.67 { 0.02, Among the groups given free access to food, plasma arachidonic acid concentrations were highest in rat groups fed the 2.36 { 0.03 and 2.03 { 0.02 mmol/L plasma, respectively. Interestingly, the portion of total plasma EFA that was present 10% CO and 5% CO / 5% OV diets. Plasma oleic acid concentrations were increased (P Å 0.002) by ingestion of as arachidonic acid increased as the concentration of plasma EFA decreased. The regression lines in Figure 2 illustrate the olive oil. TFA concentrations in arterial blood plasma were directly relationships between the EFA concentration and the ratio of linoleic:arachidonic acid in arterial blood plasma in rat groups dependent (P Å 0.002) on the dietary fatty acid concentration (Table 2) in rat groups given free access to food. Identical given free access to food and in the energy-restricted rat groups. Ingestion of diets containing low linoleic acid decreased both concentrations were observed in the three rat groups fed diets containing 10% fat (mean for the 3 groups Å 10.56 { 0.08 total plasma EFA and the ratio of linoleic:arachidonic acid in arterial blood plasma. In rats given free access to food (Fig. mmol/L). Plasma TFA concentrations in the other groups were as follows: fat-free diet, 3.8 { 0.03 mmol/L; 2% CO diet, 8.97 2A), elevated plasma EFA concentrations, associated with an increased dietary linoleic acid intake, increased plasma linoleic { 0.1 mmol/L; 5% CO diet, 8.45 { 0.15 mmol/L; and 7.5% CO diet, 9.38 { 0.04 mmol/L. Plasma TFA concentrations in acid concentrations more than arachidonic acid concentrations. This effect was most marked in energy-restricted rat the energy-restricted rat groups were not significantly different (mean for the four groups Å 5.75 { 0.05 mmol/L) despite the groups (Fig. 2B) ; plasma arachidonic acid concentrations were essentially unchanged despite a doubling of linoleic acid con-different dietary fat intakes. Plasma fatty acid concentrations and tumor growth. Fig-centrations .
Plasma concentrations for palmitic / stearic acids and lino-ure 3A-D also includes the mean tumor growth rates for the 11 rat groups (see also Table 3 ). Comparison of plasma fatty leic, arachidonic and oleic acids among the 11 dietary groups are shown on the x-axes of Figure 3A-D. The lowest concen-acid concentrations to tumor growth rates among rat groups given free access to diets containing added fat showed that trations were observed in rats given free access to the fat-free diet. Energy restriction also decreased the concentrations and tumor growth was independent of the plasma levels of either palmitic / stearic (Fig. 3A) or oleic acids (Fig. 3D ). Animal ranges of each fatty acid relative to cohort groups given free access to food. Despite differences in palmitic / stearic acid groups with identical plasma concentrations of these fatty acids / 4w20$$0019 06-02-97 22:50:31 nutras LP: J Nut July different (P Å 0.317). However, the intercepts, which were 0.697 and 00.172, respectively, were significantly different (P Å 0.001); relative to tumor growth in rats given free access to food, energy restriction caused a decrement in tumor growth equivalent to about 0.9 g wet weight/d. Dietary fat and tumor lipid metabolism. The concentrations of linoleic acid and TFA in tumor lipids (Table 4) were increased as the plasma linoleic acid concentrations (Fig. 3) were increased in rats given free access to food and in energyrestricted rats. An increase in tumor triacylglycerols caused the increase in tumor lipid content. Remarkably, the TFA concentration in tumor triacylglycerols was independent of the dietary (Table 2 ) and plasma TFA concentrations (see above). Diets that contained equivalent linoleic acid concentrations but different total fat levels (2% CO and 10% OV) yielded tumors with similar linoleic acid and TFA concentrations. Also, tumors from rats given free access to either the 5% CO diet or the 5% CO / 5% OV diet contained similar linoleic and TFA concentrations.
Unlike the linoleic and TFA concentrations in triacylglycerols, fatty acid concentrations in tumor free fatty acids, phospholipids and cholesterol esters were similar among the 11 rat groups. Mean tumor linoleic and TFA concentrations (mmol/ 100 g tumor wet weight) for these groups were as follows: free fatty acids, 0.12 { 0.09 and 0.72 { 0.13; phospholipids, 0.23 { 0.02 and 2.3 { 0.2; and cholesterol esters, 0.03 { 0.004 and 0.17 { 0.01, respectively.
Arteriovenous difference measurements across hepatoma 7288CTC in vivo and during perfusion in situ indicated that 13-HODE was absent from arterial blood but present in tumor venous blood. The rates of release from the tumor were directly FIGURE 2 Correlations between the ratio of linoleic:arachidonic correlated (P õ 0.001) to the rates of linoleic acid uptake acid and plasma linoleic / arachidonic acid concentrations in rats given (Fig. 4) . About 3% of the linoleic acid removed from arterial free access to food or energy-restricted. Mean daily arterial blood blood by hepatoma 7288CTC was converted to 13-HODE. plasma. Table 5 also shows that 14 C-linoleic acid uptake was KODE were released into the tumor venous blood during perfusion with 14 C-arachidonic acid but were not radiolabeled. No 12-or 15-HETE, either radiolabeled or nonradiolabeled, was showed significantly different rates of tumor growth and vice detected in tumor venous blood from either experiment. A versa. Differences in tumor growth rate in the four energyportion of the radiolabeled linoleic and arachidonic acids rerestricted rat groups were not associated with differences in moved from the arterial blood was incorporated into tumor either plasma palmitic / stearic, arachidonic or oleic acid lipids. 14 C-Linoleic acid was incorporated into tumor triacylconcentrations. Positive associations were observed between glycerols and phospholipids; however, 14 C-arachidonic acid mean plasma linoleic acid concentrations and mean tumor was incorporated mainly into phospholipids and cholesterol growth rates (Fig. 3B ) in rat groups given free access to food esters. (P õ 0.001) and in energy-restricted rats (P Å 0.008). A positive relationship was also observed between the plasma arachidonic acid concentration and tumor growth ( Fig. 3C) DISCUSSION in rats given free access to food (P Å 0.04). The slopes of the regression lines for plasma linoleic acid concentrations and These experiments were designed to measure quantitative relationships among dietary fatty acid intake, arterial blood tumor growth in rat groups given free access to food (m Å 0.425) and for energy-restricted rats (m Å 0.812) were not plasma fatty acid concentrations and growth and metabolism / 4w20$$0019 06-02-97 22:50:31 nutras LP: J Nut July
FIGURE 3
The effect of mean daily arterial blood plasma concentrations of (A) palmitic / stearic, (B) linoleic, (C) arachidonic and (D) oleic acids on mean tumor growth rates in rats given free access to food or energy-restricted. Symbols are the same as in Figure 2 . Regression lines and 95% confidence intervals indicate significant correlations. In (B), mean plasma linoleic acid concentrations were different (P õ 0.05) for all dietary group pairs given free access to food, except groups fed the 7.5% corn oil (CO) and 5% CO / 5% olive oil (OV) diets and the 10% OV and 2% CO diets. Mean plasma linoleic acid concentrations in energy-restricted groups were different (P õ 0.05), except for groups fed 10% CO and 7.5% CO diets. In (B), for rats given free access to food, tumor growth rate Å 0.425 (plasma linoleic acid concentration) / 0.697, P õ 0.001, r Å 0.956 and for energy-restricted rats, tumor growth rate Å 0.812 (plasma linoleic acid concentration) 0 0.172, P Å 0.008, r Å 0.992. Slopes were not different, P Å 0.317; intercepts were different, P Å 0.000013. In (C), for rat groups given free access to food, tumor growth rate Å 0.605 (plasma arachidonic acid concentration) / 0.482, P Å 0.04, r Å 0.776.
TABLE 4
Effect of dietary fat level and feeding regimen of rats on the linoleic acid and total fatty acid concentrations of tumor total lipids and triacylglycerols The values in parentheses are percentage of total present as linoleic acid. For comparison of differences among groups, values in a column within a feeding regimen with different superscript letters are different (P õ 0.05).
3 Abbreviations used: CO, corn oil; OV, olive oil.
/ 4w20$$0019 06-02-97 22:50:31 nutras LP: J Nut July single blood samples were drawn, the times of blood sampling during the diurnal feeding cycle were not designated and the fatty acid compositions were not quantified. Quantitative data described here show changes in plasma fatty acid concentrations and tumor growth rates associated with ingestion of seven semipurified diets containing different corn and olive oil concentrations. The central findings were that tumor growth, lipid storage and rate of 13-HODE formation were dependent on dietary linoleic acid intake and the plasma linoleic acid concentration. Growth of hepatoma 7288CTC became limited at plasma linoleic acid concentrations°3 mmol/L. Although this tumor removes free fatty acids, triacylglycerols, phospholipids and cholesterol esters from arterial blood (Sauer and Dauchy 1992a) , it is not known which lipid class is most important in supplying the linoleic acid-dependent growth requirement. Some evidence suggests that free linoleic acid performs this function. We have previously shown that 0.6-0.7 mmol/L plasma free linoleic acid supported peak rates of 3 H-thymidine incorporation in hepatoma 7288CTC perfused in situ (Sauer and Dauchy 1992b) . A similar plasma free linoleic acid concentration (0.78 { 0.15 mmol/L) was present in arterial blood of the rats given free access to the 10% CO diet. Also, free linoleic acid has a positive growth effect when added to tumor cells cultured in serum-free media. If 13-HODE production is necessary for the linoleic acid-dependent FIGURE 4 Correlation between the rates of release of 13-hydroxy-9,11-octadecadienoic acid (13-HODE) into the tumor venous blood and growth requirement, the discrepancy between the specific acplasma linoleic acid uptake by hepatoma 7288CTC in vivo and during tivities of 14 C-13-HODE in tumor venous blood and plasma perfusion in situ. Each point represents a single measurement: rate of free 14 C-linoleic acid in arterial blood suggests that unlabeled tumor 13-HODE release Å 0.035 (rate of tumor linoleic acid uptake) / linoleic acid sources, e.g., triacylglycerols, phospholipids and/ 0.038, P õ 0.001, r Å 0.956, n Å 54.
or cholesterol ester, contributed to 13-HODE production. However, the 14 C-13-HODE specific activity may have been underestimated. Because of the low concentrations of 13in a solid rat tumor in vivo. Information was available on the HODE present in tumor venous blood, the determinations effects of dietary fat on plasma fatty acid composition during were made using pooled plasma samples. This may have obcarcinogen-induced tumorigenesis (Cohen et al. 1986 , Hirose et al. 1990 , Sundram et al. 1989 ), but in those experiments scured increases in specific activity that occurred during the / 4w20$$0019 06-02-97 22:50:31 nutras LP: J Nut July perfusion. Also, because no adequate tracer was available, we access to food. An increment in plasma linoleic acid concentration caused an equivalent increment in tumor growth in were unable to correct for 13-HODE losses during the extraction and chromatographic procedures. The results in Table 5 rats on both feeding regimens. The intercepts of the regression lines on the y-axis were different (Fig. 3B) , however, indicating clearly show that plasma free linoleic acid was converted to 13-HODE, but other plasma linoleic acid sources cannot yet that energy restriction removed a tumor growth stimulative effect that was expressed in rats given free access to food. To be ruled out.
Except for arachidonic acid, which was shown to support our knowledge, these data are the first evidence showing that decreased plasma linoleic acid concentrations and decreased a weak but significant tumor growth requirement (P Å 0.04), no other plasma fatty acid examined appeared to be directly energy intakes may contribute separately to reduce tumor growth rates during energy restriction. involved in tumor growth. Tumors grown in EFA-deficient rats that were perfused in situ with donor blood from other Although the mechanism through which plasma linoleic acid affects tumor growth is not yet known, recent evidence EFA-deficient rats demonstrated an arachidonate-dependent 3 H-thymidine incorporation that reached a V max at 0.3-0.4
indicates that 13-HODE, a metabolite formed from linoleic acid by lipoxygenase, acts to augment EGF-dependent mito-mmol/L added plasma free arachidonate (Sauer and Dauchy 1992b) . Plasma free arachidonic acid concentrations (gener-genesis (Glasgow and Eling 1994) . Inhibitors of cyclooxygenase and lipoxygenase are known to inhibit carcinogen-induced ally about 25% of the total concentration) equaled or exceeded these values in all of the rat groups examined here except rats tumorigenesis and tumor growth promoted by high fat diets. We investigated 13-HODE production in hepatoma 7288CTC fed the fat-free diet (Fig. 3, 4) . Hillyard and Abraham (1979) demonstrated a linoleic acid growth requirement in mammary in vivo because of the strong linoleic acid growth requirement and the weak or absent arachidonic acid requirement. 13-adenocarcinoma growing in BALB/c mice given free access to a fat-free diet but found no arachidonic acid growth require-HODE was released into the tumor venous blood at substantial rates in vivo and during perfusion in situ (Fig. 4) , and rates ment. Preferential conversion of linoleic acid to arachidonic acid in rats fed low linoleic acid concentrations (Fig. 2) may of release were directly dependent on the plasma linoleic acid concentrations. Radiolabeled 13-HODE and 13-KODE were provide sufficient plasma arachidonic acid to satisfy the arachidonic acid-dependent growth requirement. Evidence for this formed from plasma free 14 C-linoleic acid. Factors that blocked 13-HODE production inhibited tumor growth. For example, conversion was also observed in normal suckling (Iritani et al. 1993 ) and adult rats (Nelson et al. 1987 ) fed low linoleic acid the inhibition of linoleic acid uptake in hepatoma 7288CTC by physiological amounts of melatonin inhibited 13-HODE concentrations. Unless animals are EFA-deficient, the specific tumor arachidonic acid-dependent growth processes are prob-release and tumor growth (Sauer et al. 1996) .
[Also, recent unpublished results (Sauer, L.A., Blask, D.E. and Dauchy, ably saturated.
A specific growth requirement for linoleic acid in vivo does R.T.) show that the lipoxygenase inhibitor, nordihydroguaiaretic acid, inhibited tumor growth and 13-HODE release with-not agree with the growth requirement for linoleic, oleic or arachidonic acid demonstrated in tumor cell lines in culture.
out affecting fatty acid uptake.] Thus, these data support and extend the hypothesis that 13-HODE is the critical substance, Mouse and rat tumor cells (Holley et al. 1974 , Keler and Sorof 1993 , Wicha et al. 1979 ) and human breast carcinoma cells generated by the tumor from plasma linoleic acid, that links increased linoleic acid ingestion to increased tumor growth. (Rose and Connolly 1990, Shultz et al. 1992 ) grown in fatty acid-deficient media showed a positive growth response to added linoleic acid. Saturated fatty acids were either without
